Dr. Simon Plyte, Biomunex’s CSO, has been invited to present MAIT engagers preclinical data during an oral communication at 2025 SITC Annual meeting With a very attractive safety and efficacy profile, ...

Ipsen secures exclusive global rights to develop, manufacture and commercialize BMX-502, a pre-clinical novel T cell engager (TCE) with first-in-class potential BMX-502 is a bispecific antibody ...

Type 1 diabetes (T1D) is an autoimmune disease that develops when the immune system attacks beta cells in the pancreas. This destructive process is often attributed to autoreactive T lymphocytes. Yet ...

CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells exacerbate inflammation and lead to chronic disease in certain conditions.

Bi- and multi-specific antibodies hold enormous promise for the next generation of precision cancer immunotherapies as they enable novel mechanisms of action such as redirecting T cell activation, ...

Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory illnesses is incomplete, which has severely hampered the development of ...